LH
LABCORP HOLDINGS INC.
NYSE: LH · Burlington, NC · Healthcare
$273.42+4.23 (+1.57%)Closed
Market Cap$22.48B
Cash$532.3Mmost recent
Runwayprofitable
P/E (TTM)26.1EPS $10.46
52-Wk Range$217.91 – $289.43
Avg Volume706.4K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$273.42+37.8%
Pipeline
Drug candidates sponsored by LABCORP · ClinicalTrials.gov
| Phase | Drug / Candidate | Indications | Status | Next Completion | Trials | |
|---|---|---|---|---|---|---|
| N/A | Unnamed | Oncology+4 more | Suspended | 2022-08-03past | 1 | |
| N/A | Unnamed | Lung Cancer+12 more | Completed | 2024-12-31past | 1 |
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for LH. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.